Cargando…

Developments in HIV-1 immunotherapy and therapeutic vaccination

Since the human immunodeficiency virus (HIV-1) pandemic began, few prophylactic vaccines have reached phase III trials. Only one has shown partial efficacy in preventing HIV-1 infection. The introduction of antiretroviral therapy (ART) has had considerable success in controlling infection and reduci...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Peter Lawrence, Tanner, Helen, Dalgleish, Angus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047951/
https://www.ncbi.nlm.nih.gov/pubmed/24991420
http://dx.doi.org/10.12703/P6-43